File Download
Patent History
- ApplicationUS 12/866118 2009-02-04
- PublicationUS 20110009369 2011-01-13
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
published patent: ANTI-INFLUENZA COMPOUNDS
Title | ANTI-INFLUENZA COMPOUNDS |
---|---|
Priority Date | 2009-02-04 US 12/866118 2008-02-05 US 12/026167P 2009-02-04 PCT/CA2009000133 |
Inventors | |
Issue Date | 2009 |
Citation | US Published patent application US 20110009369. Washington, DC: US Patent and Trademark Office (USPTO), 2011 How to Cite? US Published patent application US 8673884. Washington, DC: US Patent and Trademark Office (USPTO), 2014 How to Cite? |
Abstract | The present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza. In particular, the compounds of the invention may be used for the treatment or prophylaxis of influenza A, most particularly H1N1 or H5N1 influenza. The compounds of the invention can also be used for the treatment or prophylaxis of a disease caused by Vibrio cholerae, Clostridium perfringens, Streptococcus pneumoniae, Arthrobacter sialophilus, an orthomyxovirus, a paramyxovirus, a parainfluenza virus, mumps virus, Newcastle disease virus, fowl plague virus or Sendai virus. |
Persistent Identifier | http://hdl.handle.net/10722/62454 |
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2010-07-13T04:01:35Z | - |
dc.date.available | 2010-07-13T04:01:35Z | - |
dc.date.issued | 2009 | en_HK |
dc.identifier.citation | US Published patent application US 20110009369. Washington, DC: US Patent and Trademark Office (USPTO), 2011 | en_HK |
dc.identifier.citation | US Published patent application US 8673884. Washington, DC: US Patent and Trademark Office (USPTO), 2014 | - |
dc.identifier.uri | http://hdl.handle.net/10722/62454 | - |
dc.description.abstract | The present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza. In particular, the compounds of the invention may be used for the treatment or prophylaxis of influenza A, most particularly H1N1 or H5N1 influenza. The compounds of the invention can also be used for the treatment or prophylaxis of a disease caused by Vibrio cholerae, Clostridium perfringens, Streptococcus pneumoniae, Arthrobacter sialophilus, an orthomyxovirus, a paramyxovirus, a parainfluenza virus, mumps virus, Newcastle disease virus, fowl plague virus or Sendai virus. | en_HK |
dc.language | eng | en_HK |
dc.title | ANTI-INFLUENZA COMPOUNDS | en_HK |
dc.type | Patent | en_HK |
dc.identifier.email | Lau, ASY: asylau@hku.hk | en_HK |
dc.identifier.email | Lau, ASY: asylau@hku.hk | en_HK |
dc.identifier.email | Lau, ASY: asylau@hku.hk | en_HK |
dc.identifier.email | Law, HY: lawanna@HKUCC.hku.hk | en_HK |
dc.identifier.email | Law, HY: lawanna@HKUCC.hku.hk | en_HK |
dc.identifier.email | Law, HY: lawanna@HKUCC.hku.hk | en_HK |
dc.identifier.email | Lee, DCW: dcwlee@HKUCC-COM.hku.hk | en_HK |
dc.identifier.email | Lee, DCW: dcwlee@HKUCC-COM.hku.hk | en_HK |
dc.identifier.email | Lee, DCW: dcwlee@HKUCC-COM.hku.hk | en_HK |
dc.identifier.email | Poon, LLM: llmpoon@hkucc.hku.hk | en_HK |
dc.identifier.email | Poon, LLM: llmpoon@hkucc.hku.hk | en_HK |
dc.identifier.email | Poon, LLM: llmpoon@hkucc.hku.hk | en_HK |
dc.identifier.authority | Lau, ASY=rp00474 | en_HK |
dc.identifier.authority | Lau, ASY=rp00474 | en_HK |
dc.identifier.authority | Lau, ASY=rp00474 | en_HK |
dc.identifier.authority | Poon, LLM=rp00484 | en_HK |
dc.identifier.authority | Poon, LLM=rp00484 | en_HK |
dc.identifier.authority | Poon, LLM=rp00484 | en_HK |
dc.description.nature | published_or_final_version | - |
dc.identifier.hkuros | 161136 | en_HK |
dc.contributor.inventor | Jones, S | en_HK |
dc.contributor.inventor | Lau, ASY | en_HK |
dc.contributor.inventor | An, JH | en_HK |
dc.contributor.inventor | Law, HY | en_HK |
dc.contributor.inventor | Lee, DCW | en_HK |
dc.contributor.inventor | Poon, LLM | en_HK |
patents.identifier.application | US 12/866118 | en_HK |
patents.description.assignee | BRITISH COLUMBIA CANCER AGENCY BRANCH [CA] | en_HK |
patents.description.country | United States of America | en_HK |
patents.date.publication | 2011-01-13 | en_HK |
patents.identifier.hkutechid | PAED-2007-00268-1 | - |
patents.date.application | 2009-02-04 | en_HK |
patents.date.priority | 2009-02-04 US 12/866118 | en_HK |
patents.date.priority | 2008-02-05 US 12/026167P | en_HK |
patents.date.priority | 2009-02-04 PCT/CA2009000133 | en_HK |
patents.description.cc | US | en_HK |
patents.identifier.publication | US 20110009369 | en_HK |
patents.identifier.publication | US 8673884 | - |
patents.relation.family | CA 2713848 (A1) 2009-08-13 | en_HK |
patents.relation.family | WO 2009097682 (A1) 2009-08-13 | en_HK |
patents.description.kind | A1 | en_HK |
patents.type | Patent_published | en_HK |